Valuation check: MDGS's profit margin is -13.06%, below the Healthcare sector average of 13.89%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2023
Trailing 12 months ending Jun 2023
Medigus (MDGS) currently reports a profit margin of -13.06% as of June 2023. That compares with -0.21% in the prior-year period — down 6127.6% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Medigus's profit margin history and peer comparisons.
Medigus's profit margin decreased from -0.21% to -13.06% — a 6127.6% year-over-year decrease (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Medigus's profit margin of -13.06% is lower than the Healthcare sector average of 13.89%. That is roughly 194.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' profit margin, but Medigus's current -13.06% should be judged against Healthcare norms (sector average: 13.89%) and against MDGS's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current profit margin of -13.06%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Medigus, and consider following MDGS for alerts when major investors trade the stock.